At ITMO It’s hard to name one single success. One of the big events was the launch of the Laboratory of Genomic Diversity under the supervision of Stephen J. O’Brien. The aim of the lab is to study genomes with a specific focus on endangered species. There is also the successful first batch of graduates from ITMO’s Master’s program Bioinformatics and Systems Biology. Thirdly, there was the win in the MEDIC contest, in which contestants had to predict the type of digestive inflammatory disease based on microbiota analysis. In terms of research, we have published several significant papers that beautifully bring together the competencies of our staff: about an algorithm that allows us to build more precise histories of human and animal populations and about a method of evaluating certain genes’ involvement in biological processes. |
At ITMO It’s difficult to point out a single major discovery or invention – most of them are important and show a lot of promise. Our young scientists are, too, developing high-tech express testing systems: this year, they’ve designed an original immunoenzymometric test system based on gliadin, which can be used to assess the quality of gluten-free products. Our PhD students have suggested highlighting another project led by our Faculty’s researchers: a feed additive designed to reduce the growth of key infectious disease pathogens among honey bees. The additive includes immunomodulatory agents based on natural β-glucosanes and chitosan – components that improve immunocompetence. This approach has not only an obvious practical value to agriculture, but also a lot of potential in terms of developing versions for other types of organisms. |
At ITMO Early in the year, we switched from studying logic gates based on light-controlled ion fluxes on nanostructured titanium dioxide and chemical perceptrons in infochemistry to applying our knowledge in the fields of electrochemistry and analytics, which are essential to the diagnostics of viruses and antibodies. Scientists have proposed a method for selective recognition of antibodies, antigens and their complexes when analyzing the shape of the curves, their area, and the position of the peaks on the curves that show dependence of the current on the potential. This method is a promising one for the analysis of a wide range of viruses, including the causative agent of COVID-19, and corresponding antibodies with electrochemical detection. An electrochemical sensing platform (ESP) has been proposed for the detection of viral pathogens in humans and animals. It can also be used in bioelementology. The ESP includes a portable hardware and software complex for express diagnostics, as well as nanostructured electrodes and test kits. We’ve also developed data processing software that uses machine learning and big data analysis methods. The developed detection systems make it possible for hospital staff to conduct analysis without requiring any special training. Moreover, the ESP can be potentially used for express analysis at home. |